TMDX TransMedics Group Inc

P/E 20.51
Forward P/E 37.31
Price/Sales 3.956
Beta 1.926
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ TransMedics Group is trading 4.82% down today with no confirmed catalyst

TransMedics Group is trading 4.82% down at $72.83, with no confirmed catalyst for the October 16 move. - No fresh company announcement explaining the move...

🟒 TransMedics Group is trading 4.3% up in pre-market amid a healthcare-sector rally

TransMedics Group is trading at $79.80, up 4.29%, in pre-market on October 16, 2026; healthcare-sector strength is the clearest available context for the...

πŸ”΄ TransMedics Group is trading 4.25% down today amid inflation and Treasury-yield concerns

TransMedics Group is trading at $75.77, down 4.25%, during the October 14 session amid broad market pressure as September inflation data renewed concerns about...

🟒 TransMedics Group is trading 4.44% up in pre-market with no confirmed company-specific catalyst

TransMedics Group is trading 4.44% up at $82.51 in pre-market; no fresh company-specific announcement explaining the move surfaced in the search. - Shares are...

πŸ”΄ TransMedics Group falls 4.2% β€” Healthcare Stocks Fall on Broad Market Geopolitical and Rate Fears

With Healthcare (XLV) down 1.5%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector declined, mirroring a wider...

TransMedics Gains on New 'Overweight' Rating from Barclays

TransMedics Gains on New 'Overweight' Rating from Barclays

Barclays initiated coverage on TransMedics Group (TMDX) on Wednesday, assigning the medical technology company an "overweight" rating. The bank set a price...

🟒 TransMedics Group is trading 4.1% up; no clear company-specific catalyst identified

TransMedics Group is trading 4.1% higher at $83.58, with no clear company-specific catalyst identified. - The gain comes as major indexes fall; healthcare is...

🟒 TransMedics Group is trading 4.02% up with no clear catalyst identified

TransMedics Group is trading at $83.00 (+4.02%); available coverage has not established a specific cause for the intraday gain. - The company’s latest listed...

πŸ”΄ TransMedics Group is trading 4.04% down; no clear company-specific catalyst

TransMedics Group is trading at $80.08, down 4.04%, with no clear company-specific catalyst identified in available news. - The latest spotlight article covers...

πŸ”΄ TransMedics Group is trading 4.4% down today as Treasury yields hit a 19-year high

TransMedics Group is trading 4.4% lower now at $83.15 as higher Treasury yields and broad risk-off trading pressure growth-oriented healthcare stocks. - The...

🟒 TransMedics Group is trading 40.21% up in after-hours trading β€” no confirmed catalyst identified

TransMedics Group is trading 40.21% up at $123.48 in after-hours trading, with no confirmed company-specific catalyst identified. - The company closed at...

TransMedics targets 20,000 U.S. transplants by 2030, launching next-gen tech

TransMedics set a target of 10,000 U.S. National OCS Program (NOP) cases by 2028. The company aims to reach 20,000 annual cases by 2030. Management expects to...

🟒 TransMedics Group is trading 4.08% up today as healthcare gains 1.28%

TransMedics Group is trading at $85.53, up +4.08%, as healthcare gains 1.28%, suggesting defensive sector rotation is supporting the move. β€’ No new...

πŸ”΄ TransMedics Group is trading 4.3% down today β€” no clear company-specific catalyst identified

TransMedics Group is trading at $81.35, with a -4.34% change and no clear company-specific catalyst identified for the September 11, 2026 decline. - Fernando...

TransMedics Appoints New CFO Fernando Araujo, Reaffirms 2026 Revenue Guidance

TransMedics Appoints New CFO Fernando Araujo, Reaffirms 2026 Revenue Guidance

TransMedics announced the appointment of Fernando Araujo as its new Chief Financial Officer and Treasurer, effective September 21, 2026. Mr. Araujo, previously...

πŸ”΄ TransMedics Group is trading 5% down in after-hours trading as Nasdaq Composite falls 0.65%

TransMedics Group is trading at $85.76, down 4.69% in after-hours trading amid weaker broader-market sentiment after closing at $89.98 on September 4, 2026. -...

πŸ”΄ TransMedics Group is trading 4.38% down today after no clear company-specific announcement was identified

TransMedics Group is trading at $84.56 (-4.38%) after no clear company-specific announcement was identified for August 31, 2026. β€’ Recent filings list August...

🟒 TransMedics Group is trading 4.09% up today as healthcare stocks rally

TransMedics Group is trading 4.09% up at $94.57 as healthcare stocks rally alongside broader risk-on sentiment. - No clear company-specific announcement...

🟒 TransMedics Group rises 4.4% β€” Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation

With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...

🟒 TransMedics Group rises 4.2% β€” Healthcare Sector Rallies on Defensive Rotation Amid Broad Market Weakness

With Healthcare (XLV) up 1.6%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector, as measured by the XLV ETF,...